original ) (raw )Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging
Jianxun Qu
Medicine, 2017
View PDFchevron_right
Differentiation between progression and pseudoprogression by arterial spin labeling MRI in patients with glioblastoma multiforme
Ruzica Maksimovic
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 2017
View PDFchevron_right
MRI perfusion in determining pseudoprogression in patients with glioblastoma
Kathryn Beal
Clinical Imaging, 2013
View PDFchevron_right
Advanced magnetic resonance techniques in early differentiation of pseudo-progression vs. progression in patients with glioblastoma multiforme
Jelena Mihailovic
Vojnosanitetski pregled, 2017
View PDFchevron_right
Comparative Evaluation of 3-Dimensional Pseudocontinuous Arterial Spin Labeling With Dynamic Contrast-Enhanced Perfusion Magnetic Resonance Imaging in Grading of Human Glioma
Amit Bindal
Journal of Computer Assisted Tomography, 2013
View PDFchevron_right
Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method
Ahmet Bekar
European Journal of Radiology, 2014
View PDFchevron_right
Arterial spin labeling in the grading of brain gliomas: could it help?
doaa emara
Egyptian Journal of Radiology and Nuclear Medicine, 2020
View PDFchevron_right
Perfusion MRI of brain tumours: a comparative study of pseudo-continuous arterial spin labelling and dynamic susceptibility contrast imaging
Carsten W Simonsen
Neuroradiology, 2010
View PDFchevron_right
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
Joseph Heiserman
Neuro-oncology, 2012
View PDFchevron_right
Glioblastoma: A Method for Predicting Response to Antiangiogenic Chemotherapy by Using MR Perfusion Imaging—Pilot Study 1
Wanyong Shin
Radiology, 2010
View PDFchevron_right
Early Evaluation of Tumoral Response to Antiangiogenic Therapy by Arterial Spin Labeling Perfusion Magnetic Resonance Imaging and Susceptibility Weighted Imaging in a Patient With Recurrent Glioblastoma Receiving Bevacizumab
Olivier Chinot
Journal of Clinical Oncology, 2011
View PDFchevron_right
Arterial Spin-Labeling Perfusion MRI Stratifies Progression-Free Survival and Correlates with Epidermal Growth Factor Receptor Status in Glioblastoma
Noriko Salamon
View PDFchevron_right
Variability and accuracy of different software packages for dynamic susceptibility contrast magnetic resonance imaging for distinguishing glioblastoma progression from pseudoprogression
Bradley Erickson
Journal of Medical Imaging, 2015
View PDFchevron_right
A Comparative Study of Perfusion Measurement in Brain Tumours at 3 Tesla MR: Arterial Spin Labeling versus Dynamic Susceptibility Contrast-Enhanced MRI
Giovanni Marco
European Neurology, 2010
View PDFchevron_right
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma
Benjamin Ellingson
American Journal of Clinical Oncology, 2017
View PDFchevron_right
Prognostic value of blood flow measurements using arterial spin labeling in gliomas
J. Schittenhelm , Ulrike Ernemann
PloS one, 2014
View PDFchevron_right
The Use of MR Perfusion Imaging in the Evaluation of Tumor Progression in Gliomas
Ashish Shah
Journal of Korean Neurosurgical Society, 2017
View PDFchevron_right
Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis
Roger Josefsen
Neuroradiology, 2011
View PDFchevron_right
Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma
Samuel Bergamaschi
Nature Communications, 2019
View PDFchevron_right
Arterial spin labeling perfusion: Prospective MR imaging in differentiating neoplastic from non-neoplastic intra-axial brain lesions
Prabhaker Mishra
The neuroradiology journal, 2018
View PDFchevron_right
MRI Parameters and Their Impact on the Survival of Patients with Glioblastoma: Tumor Perfusion Predicts Survival
Ogaga Urhie
World Neurosurgery, 2018
View PDFchevron_right
Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients
Jayashree Kalpathy-cramer , Kourosh Jafari-khouzani
Translational Oncology, 2015
View PDFchevron_right
Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI
Sanjeev Chawla, PhD. DABMP
View PDFchevron_right
Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas
Andreas Fotopoulos
Contrast Media & Molecular Imaging, 2018
View PDFchevron_right
Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation
Danielle Ibarrola
European Radiology, 2016
View PDFchevron_right
Early changes in perfusion of glioblastoma during radio- and chemotherapy evaluated by T1-dynamic contrast enhanced magnetic resonance imaging
Svend Engelholm
Acta Oncologica, 2015
View PDFchevron_right
Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients
Vasileios K. Katsaros
Neuroradiology, 2016
View PDFchevron_right
Differentiation Between True Tumor Progression of Glioblastoma and Pseudoprogression Using Diffusion-Weighted Imaging and Perfusion-Weighted Imaging: Systematic Review and Meta-analysis
Anastasia Zikou
World Neurosurgery, 2020
View PDFchevron_right